Title
Category
Credits
Event date
Cost
- Pathology
$0.00
The Pathology module provides lectures that focus on the updated WHO classification system and will feature current hot topics of interest related to the pathological classification of specific tumor types. The module features up-to-date information for adult and pediatric patient populations.Education Committee Chairs: Patrick Wen, Isabel Arrillaga-RomanyCo-Chair: Beatriz LopesTopics in this track include:
- Pathology
$0.00
The Society for Neuro-Oncology's Molecular Pathology Special Interest Track is pleased to present the SNO Pathology FAST (First Author Series Talk) quarterly webinar series. Registration is free and limited to the first 1,000 participants. All SNO webinars are recorded, so if you miss one, you will be able to view it on-demand on the Neuro-Oncology Academy.
- Pathology
- 1.00 Attendance
$0.00
The Society for Neuro-Oncology and the Molecular Pathology Special Interest Track is pleased to announce the SNO Pathology FAST (First Author) Talk series.Molecular Pathology Special Interest Track-Current Advances in Melanoma and Brain MetastasesMelanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain MetastasisComplimentary Registration!
- Pathology
- 1.00 Attendance
$0.00
Molecular Pathology Special Interest Track Quarterly Series: Tuesday February 21, 2023, at 1:00 pm ET- 2:00 pm ETPyrimidine synthesis in IDH-mutant glioma: Identification of BAY 2402234 as a novel therapeutic strategyComplimentary Registration!
- Pathology
- 1.00 Attendance
$0.00
Highlights of SNO-EANO 2022: Tuesday February 14, 2023, at 12:30pm-1:30pm ESTComplimentary Registration!Registration is free and limited to the first 1,000 participants. All SNO webinars are recorded, so if you miss one, you will be able to view it on-demand through the Neuro-Oncology Academy.
- Pathology
$0.00
This course will discuss principles of DNA methylation and suitability for routine brain tumor diagnostics. An overview of the method, and impact on accurate diagnostics for newly diagnosed and recurrent tumors will be presented. Furthermore, the role of DNA methylation in avoiding diagnostic errors and accurately diagnose brain tumors, which were unclassifiable using routine diagnostic tools will be discussed.
- Pathology
$0.00
Overview and update on the WHO 2021, as well as a diagnostic odyssey about CNS tumors
- Pathology
$0.00
Meningiomas: where we have been, where we are now, and where we are going
- Pathology
$0.00
Presentation on the recent updates of the classification of adult- and pediatric-type diffuse gliomas
- Pathology
$0.00
Modern diagnostics of ependymal tumorsThe WHO 2016 classification of CNS tumors regarding ependymal tumors and its limitsDNA methylation profiling, c-IMPACT-NOW updates and the WHO 2021 classification of ependymal tumorsPractical diagnostic approaches in 2021